Aligos Therapeutics Inc. (ALGS) Stock Price

5.135 ▼ -0.085 (-1.63%)
Open: 5.09 Vol: 0 Day's range: 5.09 - 5.17 Sep 14, 10:59 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
ALGS Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 5.17▼ 5.21▼ 5.22▼ 5.39▼ 6.03▼
MA10 5.21▼ 5.24▼ 5.25▼ 5.75▼ 5.67▼
MA20 5.24▼ 5.34▼ 5.51▼ 6.34▼ 5.68▼
MA50 5.48▼ 5.84▼ 5.88▼ 5.90▼ 7.22▼
MA100 5.84▼ 6.29▼ 6.41▼ 5.82▼ 11.02▼
MA200 6.28▼ 6.60▼ 6.05▼ 7.06▼ 16.26▼
  5 mins 30 mins Hourly Daily Weekly
MACD 0.005▲ 0.011▲ -0.010▼ -0.215▼ 0.106▲
RSI 26.177▼ 21.358▼ 21.028▼ 36.969▼ 43.315▼
STOCH 21.519     23.000     9.103▼ 8.675▼ 57.395    
WILL %R -80.000▼ -82.000▼ -92.623▼ -98.289▼ -69.764    
CCI -113.796▼ -215.744▼ -110.977▼ -124.509▼ -62.362    
Latest Filters Detected On ALGS
▼ GAP $ALGS Open Gap Down %2 Set Alert
▼ BREAK $ALGS Price Breaks 20 Days Low Set Alert
▼ BREAK $ALGS Price Breaks 10 Days Low Set Alert
CDL $ALGS Doji Candlestick Pattern Detected Set Alert
Aligos Therapeutics Inc. News
Aligos Therapeutics shares rise 7.6% premarket following recent company updates
Wednesday, September 02, 2026 03:45 AM
Aligos Therapeutics (NASDAQ:ALGS) shares rose 7.6% to $6.55 in premarket trading, with no specific company announcement identified in the supplied information as an immediate catalyst for the move.
Aligos Therapeutics Announces the Completion of Enrollment in the Phase 2 B-SUPREME Study of Pevifoscorvir Sodium Under Development for the Treatment of Chronic HBV Infection
Monday, July 13, 2026 05:00 AM
SOUTH SAN FRANCISCO, Calif., July 13, 2026 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”), a clinical stage biopharmaceutical company focused on developing novel therapeutics ...
Aligos Therapeutics Receives Upfront Payment of $25M USD from the Exclusive License Deal of Pevifoscorvir Sodium in Greater China for Chronic Hepatitis B Virus Infection
Sunday, July 05, 2026 04:59 PM
SOUTH SAN FRANCISCO, Calif., July 06, 2026 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company focused on improving patient outcomes through ...
ALGS historical stock data
date open high low close volume
14/09/26 5.09 5.17 5.09 5.135 7,069
11/09/26 5.39 5.5019 5.14 5.22 36,910
10/09/26 5.38 5.48 5.21 5.33 46,061
09/09/26 5.79 6.02 5.4101 5.50 32,409
08/09/26 6.21 6.3396 5.62 5.76 63,627
04/09/26 6.16 6.21 6.02 6.21 20,253
03/09/26 6.22 6.48 6.07 6.22 42,054
02/09/26 6.15 6.64 6.01 6.21 55,236
01/09/26 5.80 6.22 5.65 6.09 101,610
31/08/26 6.8196 6.8196 5.86 5.86 98,111
Quote Details
52wk Low:3.98
52wk High:13.689
Vol:0
Avg Vol(3m):3M
1Y Chng:-47.60%
1M Chng:+11.63%
Add to Watch List
More Information
Index US Composite
Market Cap. 33.28M